The observed successful in vivo targeting of JUMP jNP-DNA/miRNA-MBs to DEspR+ tumor microvascular endothelial cells likely reflects the stable binding and internalization of anti-DEspR antibodies to endothelial cells 62 and Panc1 tumor cells 63. This evidence concerns the gene FBXW7-AS1 and neoplasm.